Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Colorectal Cancer Screening 

This HEDIS Measure 

Assesses adults 50–75 who had appropriate screening for colorectal cancer with any of the following tests: annual fecal occult blood test, flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, computed tomography colonography every 5 years, stool DNA test every 3 years. 

So What?

Treatment for colorectal cancer in its earliest stage can lead to a 90 percent survival rate after five years, but more than a third of adults 50–75 do not get the recommended screening.1 Colorectal cancer screening of asymptomatic adults in that age group can catch polyps before they become cancerous or detect colorectal cancer in its early stages, when treatment is most effective. 

References

  1. American Cancer Society. 2017. “Colorectal Cancer Facts & Figures 2017-2019.” https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf
tables
Colorectal Cancer Screening Rate
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 62.0 58.3 _ 67.1 69.8
2015 62.8 57.1 67.4 66.7
2014 64.3 57.7 66.5 62.9
2013 63.3 56.6 64.3 60.8
2012 63.3 55.8 62.1 58.4
2011 62.4 54.6 60.0 55.2
2010 62.6 47.6 57.6 41.0
2009 60.7 47.0 54.9 40.1
2008 58.6 45.3 53.1 41.8
2007 55.6 42.5 50.4 39.5
2006 54.5 42.1 53.3 47.1
2005 52.3 43.4 54.0 49.7
2004 49.0 52.6